Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandip Basu

Showing results (301-310 of 520) with videos related to

Pageof 52
Sort By:
Clinical Nuclear Medicine|October 4, 2024
Variable Tracer Avidity and Interlesional Heterogeneity on 18 F-FDG, 68 Ga-DOTATATE, and 68 Ga-DOTA-FAPi-04 PET/CT Imaging in a Single Individual Patient With Progressive Metastatic Medullary Thyroid CarcinomaYeshwanth Edamadaka, Rahul V Parghane, Sandip Basu
World Journal of Nuclear Medicine|May 8, 2025
An Unusual Observation in Metastatic Neuroendocrine Neoplasm: Diffuse Pattern Hepatic [ <sup>68</sup> Ga]Ga-DOTATATE Uptake Related to Micro-metastatic Disease and Discordance between Dual-Tracer PET-CT Findings and MIB-1 Labelling IndexParth Baberwal, Sunita N Sonavane, Sandip Basu
European Journal of Nuclear Medicine and Molecular Imaging|May 21, 2015
Defining a rational step-care algorithm for managing thyroid carcinoma patients with elevated thyroglobulin and negative on radioiodine scintigraphy (TENIS): considerations and challenges towards developing an appropriate roadmapSandip Basu, Mitali Dandekar, Amit Joshi, et al.
Indian Journal of Surgical Oncology|March 27, 2014
Special Relevance of FDG-PET as an Upfront Diagnostic Modality at Initial Diagnosis and in Suspected Recurrence in Patients of Breast Carcinoma Hailing From Lower Socioeconomic Status Owing to Relative Late Presentation: A Pilot Study in a Medical College Hospital Setting in IndiaSpoorthy S Shetty, Mukund B Tayade, Sandip Basu
PET Clinics|May 10, 2016
PrefaceSandip Basu, Rakesh Kumar, Ayşe Mavi, et al.
South Asian Journal of Cancer|January 24, 2014
Positron emission tomography-computed tomography in the management of lung cancer: An updatePunit Sharma, Harmandeep Singh, Sandip Basu, et al.
Nuclear Medicine Communications|March 6, 2024
Prospective evaluation of 68 Ga-NODAGA-RGD PET-CT in patients of carcinoma thyroid with thyroglobulin elevated negative radioiodine scintigraphy (TENIS) with a head-to-head comparison with FDG-PET/CTAbhay Gondhane, Priyanka Verma, Ashok Chandak, et al.
World Journal of Nuclear Medicine|May 4, 2026
Discordance of Dual-Tracer PET/CT with Histopathology in a Grade I Pancreatic Neuroendocrine Tumor: A Diagnostic ConundrumSarina Shah, Keerti Sitani, Gauri Deshpande, et al.
PET Clinics|June 18, 2022
An Appraisal and Update of Fluorodeoxyglucose and Non-Fluorodeoxyglucose-PET Tracers in Thyroid and Non-Thyroid Endocrine NeoplasmsAadil Adnan, Shobhana Raju, Rakesh Kumar, et al.
The British Journal of Radiology|July 11, 2022
The efficacy, toxicity and survival of salvage retreatment PRRT with <sup>177</sup>Lu-DOTATATE in patients with progressive NET following initial course of PRRTKeerti Sitani, Rahul Parghane, Sanjay Talole, et al.
Pageof 52

Showing results (301-310 of 520) with videos related to

Sort By:
Pageof 52
Clinical Nuclear Medicine|October 4, 2024
Variable Tracer Avidity and Interlesional Heterogeneity on 18 F-FDG, 68 Ga-DOTATATE, and 68 Ga-DOTA-FAPi-04 PET/CT Imaging in a Single Individual Patient With Progressive Metastatic Medullary Thyroid CarcinomaYeshwanth Edamadaka, Rahul V Parghane, Sandip Basu
World Journal of Nuclear Medicine|May 8, 2025
An Unusual Observation in Metastatic Neuroendocrine Neoplasm: Diffuse Pattern Hepatic [ <sup>68</sup> Ga]Ga-DOTATATE Uptake Related to Micro-metastatic Disease and Discordance between Dual-Tracer PET-CT Findings and MIB-1 Labelling IndexParth Baberwal, Sunita N Sonavane, Sandip Basu
European Journal of Nuclear Medicine and Molecular Imaging|May 21, 2015
Defining a rational step-care algorithm for managing thyroid carcinoma patients with elevated thyroglobulin and negative on radioiodine scintigraphy (TENIS): considerations and challenges towards developing an appropriate roadmapSandip Basu, Mitali Dandekar, Amit Joshi, et al.
Indian Journal of Surgical Oncology|March 27, 2014
Special Relevance of FDG-PET as an Upfront Diagnostic Modality at Initial Diagnosis and in Suspected Recurrence in Patients of Breast Carcinoma Hailing From Lower Socioeconomic Status Owing to Relative Late Presentation: A Pilot Study in a Medical College Hospital Setting in IndiaSpoorthy S Shetty, Mukund B Tayade, Sandip Basu
PET Clinics|May 10, 2016
PrefaceSandip Basu, Rakesh Kumar, Ayşe Mavi, et al.
South Asian Journal of Cancer|January 24, 2014
Positron emission tomography-computed tomography in the management of lung cancer: An updatePunit Sharma, Harmandeep Singh, Sandip Basu, et al.
Nuclear Medicine Communications|March 6, 2024
Prospective evaluation of 68 Ga-NODAGA-RGD PET-CT in patients of carcinoma thyroid with thyroglobulin elevated negative radioiodine scintigraphy (TENIS) with a head-to-head comparison with FDG-PET/CTAbhay Gondhane, Priyanka Verma, Ashok Chandak, et al.
World Journal of Nuclear Medicine|May 4, 2026
Discordance of Dual-Tracer PET/CT with Histopathology in a Grade I Pancreatic Neuroendocrine Tumor: A Diagnostic ConundrumSarina Shah, Keerti Sitani, Gauri Deshpande, et al.
PET Clinics|June 18, 2022
An Appraisal and Update of Fluorodeoxyglucose and Non-Fluorodeoxyglucose-PET Tracers in Thyroid and Non-Thyroid Endocrine NeoplasmsAadil Adnan, Shobhana Raju, Rakesh Kumar, et al.
The British Journal of Radiology|July 11, 2022
The efficacy, toxicity and survival of salvage retreatment PRRT with <sup>177</sup>Lu-DOTATATE in patients with progressive NET following initial course of PRRTKeerti Sitani, Rahul Parghane, Sanjay Talole, et al.
Pageof 52